Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of CorMedix Inc (NASDAQ: CRMD) was $12.35 for the day, up 2.57% from the previous closing price of $12.04. In other words, the price has increased by $2.57 from its previous closing price. On the day, 2.14 million shares were traded. CRMD stock price reached its highest trading level at $12.49 during the session, while it also had its lowest trading level at $11.82.
Ratios:
Our analysis of CRMD’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.43 and its Current Ratio is at 4.79. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 26, 2024, initiated with a Buy rating and assigned the stock a target price of $13.
On August 10, 2023, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $6.
On February 17, 2021, Needham started tracking the stock assigning a Buy rating and target price of $31.Needham initiated its Buy rating on February 17, 2021, with a $31 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 13 ’24 when Todisco Joseph bought 13,561 shares for $3.74 per share. The transaction valued at 50,718 led to the insider holds 352,839 shares of the business.
DUNTON ALAN W bought 3,000 shares of CRMD for $10,350 on Dec 14 ’23. The Director now owns 12,250 shares after completing the transaction at $3.45 per share. On Dec 15 ’23, another insider, DUNTON ALAN W, who serves as the Director of the company, bought 3,000 shares for $3.30 each. As a result, the insider paid 9,900 and bolstered with 15,250 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRMD now has a Market Capitalization of 713348352 and an Enterprise Value of 644854784. For the stock, the TTM Price-to-Sale (P/S) ratio is 880.66 while its Price-to-Book (P/B) ratio in mrq is 14.78. Its current Enterprise Value per Revenue stands at 799.95 whereas that against EBITDA is -11.117.
Stock Price History:
Over the past 52 weeks, CRMD has reached a high of $12.10, while it has fallen to a 52-week low of $2.57. The 50-Day Moving Average of the stock is 62.70%, while the 200-Day Moving Average is calculated to be 139.82%.
Shares Statistics:
CRMD traded an average of 878.52K shares per day over the past three months and 1030310 shares per day over the past ten days. A total of 57.76M shares are outstanding, with a floating share count of 56.86M. Insiders hold about 1.56% of the company’s shares, while institutions hold 29.58% stake in the company. Shares short for CRMD as of 1727654400 were 9268532 with a Short Ratio of 10.55, compared to 1724976000 on 10112343. Therefore, it implies a Short% of Shares Outstanding of 9268532 and a Short% of Float of 16.600001.
